These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 28394926)
1. GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation. Zhang X; Zhu C; Wang T; Jiang H; Ren Y; Zhang Q; Wu K; Liu F; Liu Y; Wu J PLoS Pathog; 2017 Apr; 13(4):e1006321. PubMed ID: 28394926 [TBL] [Abstract][Full Text] [Related]
2. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2. Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771 [TBL] [Abstract][Full Text] [Related]
3. microRNA-125a targets MAVS and TRAF6 to modulate interferon signaling and promote HCV infection. Yan J; Zhang Y; Su Y; Tian L; Qin P; Xu X; Zhou Y Virus Res; 2021 Apr; 296():198336. PubMed ID: 33577860 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A. Vazquez C; Tan CY; Horner SM J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039 [TBL] [Abstract][Full Text] [Related]
5. Golgi protein 73 facilitates the interaction of hepatitis C virus NS5A with apolipoprotein E to promote viral particle secretion. Zhang X; Wang T; Dai X; Zhang Y; Jiang H; Zhang Q; Liu F; Wu K; Liu Y; Zhou H; Wu J Biochem Biophys Res Commun; 2016 Oct; 479(4):683-689. PubMed ID: 27697522 [TBL] [Abstract][Full Text] [Related]
6. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons. Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814 [TBL] [Abstract][Full Text] [Related]
7. Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome. Zhang L; Liu J; Qian L; Feng Q; Wang X; Yuan Y; Zuo Y; Cheng Q; Miao Y; Guo T; Zheng X; Zheng H PLoS Pathog; 2018 May; 14(5):e1007067. PubMed ID: 29734366 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921 [TBL] [Abstract][Full Text] [Related]
9. Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling. Shi Z; Zhang Z; Zhang Z; Wang Y; Li C; Wang X; He F; Sun L; Jiao S; Shi W; Zhou Z J Biol Chem; 2015 Oct; 290(44):26811-20. PubMed ID: 26385923 [TBL] [Abstract][Full Text] [Related]
10. Suppression of Host Innate Immune Response by Hepatitis C Virus via Induction of Autophagic Degradation of TRAF6. Chan ST; Lee J; Narula M; Ou JJ J Virol; 2016 Dec; 90(23):10928-10935. PubMed ID: 27681126 [TBL] [Abstract][Full Text] [Related]
11. CXCL10 decreases GP73 expression in hepatoma cells at the early stage of hepatitis C virus (HCV) infection. Liu Y; Zou Z; Zhu B; Hu Z; Zeng P Int J Mol Sci; 2013 Dec; 14(12):24230-41. PubMed ID: 24351813 [TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes. Wang YZ; Li JL; Wang X; Zhang T; Ho WZ World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081 [TBL] [Abstract][Full Text] [Related]
13. Down regulation of TRIF, TLR3, and MAVS in HCV infected liver correlates with the outcome of infection. Kar P; Kumar D; Gumma PK; Chowdhury SJ; Karra VK J Med Virol; 2017 Dec; 89(12):2165-2172. PubMed ID: 28480979 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809 [TBL] [Abstract][Full Text] [Related]
15. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon. Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells. Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus reveals a novel early control in acute immune response. Arnaud N; Dabo S; Akazawa D; Fukasawa M; Shinkai-Ouchi F; Hugon J; Wakita T; Meurs EF PLoS Pathog; 2011 Oct; 7(10):e1002289. PubMed ID: 22022264 [TBL] [Abstract][Full Text] [Related]
18. Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus. Bender S; Reuter A; Eberle F; Einhorn E; Binder M; Bartenschlager R PLoS Pathog; 2015 Nov; 11(11):e1005264. PubMed ID: 26588843 [TBL] [Abstract][Full Text] [Related]
19. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage. Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380 [TBL] [Abstract][Full Text] [Related]
20. TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism. Lee J; Tian Y; Chan ST; Kim JY; Cho C; Ou JH PLoS Pathog; 2015 May; 11(5):e1004937. PubMed ID: 26023919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]